1,380
Views
13
CrossRef citations to date
0
Altmetric
Editorial

Identifying aggressive forms of endometrioid-type endometrial cancer: new insights into molecular subtyping

, &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Musa S Ibrahim, Dong Pang, Gurch Randhawa & Yannis Pappas. (2022) Development and Validation of a Simple Risk Model for Predicting Metabolic Syndrome (MetS) in Midlife: A Cohort Study. Diabetes, Metabolic Syndrome and Obesity 15, pages 1051-1075.
Read now

Articles from other publishers (12)

Na Wang, Dan-Ni He, Zhe-Yu Wu, Xu Zhu, Xiao-Ling Wen, Xu-Hua Li, Yu Guo, Hong-Jiu Wang & Zhen-Zhen Wang. (2022) Oncogenic signaling pathway dysregulation landscape reveals the role of pathways at multiple omics levels in pan-cancer. Frontiers in Genetics 13.
Crossref
Cathleen E. Matrai, Kentaro Ohara, Kenneth Wha Eng, Shannon M. Glynn, Pooja Chandra, Sudeshna Chatterjee-Paer, Samaneh Motanagh, Susanna Mirabelli, Boaz Kurtis, Bing He, Alexandros Sigaras, Divya Gupta, Eloise Chapman-Davis, Kevin Holcomb, Andrea Sboner, Olivier Elemento, Lora Hedrick Ellenson & Juan Miguel Mosquera. (2022) Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence. International Journal of Gynecological Pathology 41:3, pages 207-219.
Crossref
Madelaine J. Cho-Clark, Gauthaman Sukumar, Newton Medeiros Vidal, Sorana Raiciulescu, Mario G. Oyola, Cara Olsen, Leonardo Mariño-Ramírez, Clifton L. Dalgard & T. John Wu. (2021) Comparative transcriptome analysis between patient and endometrial cancer cell lines to determine common signaling pathways and markers linked to cancer progression. Oncotarget 12:26, pages 2500-2513.
Crossref
Marion Polomski, Marie Brachet‐Botineau, Ludovic Juen, Marie‐Claude Viaud‐Massuard, Fabrice Gouilleux & Gildas Prié. (2021) Inhibitors Targeting STAT5 Signaling in Myeloid Leukemias: New Tetrahydroquinoline Derivatives with Improved Antileukemic Potential. ChemMedChem 16:6, pages 1034-1046.
Crossref
Danielle C. Costigan, Fei Dong, Marisa R. Nucci & Brooke E. Howitt. (2020) Clinicopathologic and Immunohistochemical Correlates of CTNNB1 Mutated Endometrial Endometrioid Carcinoma. International Journal of Gynecological Pathology 39:2, pages 119-127.
Crossref
Shuting Wu, Zeeshan Ahmad, Jing-Song Li & Ming-Wei Chang. (2020) Fabrication of flexible composite drug films via foldable linkages using electrohydrodynamic printing. Materials Science and Engineering: C 108, pages 110393.
Crossref
Yuexin Liu. (2019) A global immune gene expression signature for human cancers. Oncotarget 10:20, pages 1993-2005.
Crossref
Ajit Venniyoor. (2017) The most important questions in cancer research and clinical oncology—Question 2–5. Obesity-related cancers: more questions than answers. Chinese Journal of Cancer 36:1.
Crossref
Annalisa Di Cello, Maddalena Di Sanzo, Francesca Marta Perrone, Gianluca Santamaria, Erika Rania, Elvira Angotti, Roberta Venturella, Serafina Mancuso, Fulvio Zullo, Giovanni Cuda & Francesco Costanzo. (2017) DJ-1 is a reliable serum biomarker for discriminating high-risk endometrial cancer. Tumor Biology 39:6, pages 101042831770574.
Crossref
Katherine C. Kurnit, Bojana Djordjevic & Russell R. Broaddus. 2017. Precision Molecular Pathology of Uterine Cancer. Precision Molecular Pathology of Uterine Cancer 65 86 .
Ang Sun. 2016. Gynecological Cancers. Gynecological Cancers 23 47 .
Annalisa Di Cello, Erika Rania, Valeria Zuccalà, Roberta Venturella, Rita Mocciaro, Fulvio Zullo & Michele Morelli. (2015) Failure to recognize preoperatively high-risk endometrial carcinoma is associated with a poor outcome. European Journal of Obstetrics & Gynecology and Reproductive Biology 194, pages 153-160.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.